• 1
    Bostwick DG, Qian J. High-grade prostatic intraepithelial neoplasia. Mod Pathol 2004; 17: 36079
  • 2
    Bostwick DG, Liu L, Brawer MK, Qian J. High-grade prostatic intraepithelial neoplasia: the only accepted prostate cancer precursor lesion. Rev Urol 2004; 6: 1719
  • 3
    Park S, Shinohara K, Grossfeld G, Carroll P. Prostate cancer detection in men with prior high grade prostatic intraepithelial neoplasia or atypical prostate biopsy. J Urol 2001; 165: 140914
  • 4
    Moore CK, Karikehalli S, Nazeer T, Fisher HA, Kaufman RP Jr, Mian BM. Prognostic significance of high grade prostatic intraepithelial neoplasia and atypical small acinar proliferation in the contemporary era. J Urol 2005; 173: 702
  • 5
    Heidenreich A, Bolla M, Joniau S et al. Guidelines on Prostate Cancer. Arnhem: European Association of Urology, 2009
  • 6
    Epstein JI, Srigley J, Grignon D et al. Recommendations for the reporting of prostate carcinoma. Hum Pathol 2007; 38: 13059
  • 7
    Huggins C, Hodges C. Studies on prostatic cancer. I. The effect of castration, of estrogen, and of androgen injection on serum phos- phatases in metastatic carcinoma of the prostate. Cancer Res 1941; 1: 2937
  • 8
    Huggins C, Stevens R, Hodges C. Studies on prostatic cancer. II. The effects of castration on advanced carcinoma of the prostate gland. Arch Surg 1941; 43: 20923
  • 9
    Isbarn H, Pinthus J, Marks L et al. Testosterone and prostate cancer: revisiting old paradigms. Eur Urol 2009; 56: 4856
  • 10
    Morgentaler A, Traish AM. Shifting the paradigm of testosterone and prostate cancer: the saturation model and the limits of androgen-dependent growth. Eur Urol 2009; 55: 31021
  • 11
    Statin P, Lumme S, Tenkanen L et al. High levels of circulating testosterone are not associated with increased prostate cancer risk: a pooled prospective study. Int J Cancer 2004; 108: 41824
  • 12
    Morote J, Planas J, Ramirez C et al. Evaluation of the serum testosterone to prostate-specific antigen ratio as a predictor of prostate cancer risk. BJU Int 2009; 104: 4869
  • 13
    Yano M, Imamoto T, Suzuki H et al. The clinical potential of pretreatment serum testosterone level to improve the efficiency of prostate cancer screening. Eur Urol 2007; 51: 37580
  • 14
    Sofikerim M, Eskicorapci S, Oruç O, Ozen H. Hormonal predictors of prostate cancer. Urol Int 2007; 79: 138
  • 15
    García-Cruz E, Huguet J, Piqueras M et al. Low testosterone bioavailability is related to prostate cancer diagnose in patients submitted to prostate biopsy. World J Urol 2011; [Epub ahead of print]
  • 16
    Vermeulen A, Kaufman JM. Diagnosis of hypogonadism in the aging male. Aging Male 2002; 5: 1706
  • 17
    Lee MC, Moussa AS, Yu C, Kattan MW, Magi-Galluzzi C, Jones JS. Multifocal high grade prostatic intraepithelial neoplasia is a risk factor for subsequent prostate cancer. J Urol 2010; 184: 195862
  • 18
    Merrimen JL, Jones G, Walker D, Leung CS, Kapusta LR, Srigley JR. Multifocal high grade prostatic intraepithelial neoplasia is a significant risk factor for prostatic adenocarcinoma. J Urol 2009; 182: 48590
  • 19
    Akhavan A, Keith JD, Bastacky SI, Cai C, Wang Y, Nelson JB. The proportion of cores with high-grade prostatic intraepithelial neoplasia on extended-pattern needle biopsy is significantly associated with prostate cancer on site-directed repeat biopsy. BJU Int 2007; 99: 7659
  • 20
    Rhoden EL, Morgentaler A. Testosterone replacement therapy in hypogonadal men at high risk for prostate cancer: results of 1 year of treatment in men with prostatic intraepithelial neoplasia. J Urol 2003; 170: 234851
  • 21
    Bostwick DG. Prostatic intraepithelial neoplasia (PIN): current concepts. J Cell Biochem Suppl 1992; 16H: 109
  • 22
    Lefkowitz GK, Taneja SS, Brown J et al. Follow-up interval prostate biopsy 3 years after diagnosis of high grade prostatic intraepithelial neoplasia is associated with high likelihood of prostate cancer, independent of change in prostate specific antigen levels. J Urol 2002; 168: 14158
  • 23
    Lefkowitz GK, Sidhu GP, Torre P et al. Is repeat prostate biopsy for high-grade prostatic intraepithelial neoplasia necessary after routine 12-core sampling? Urology 2001; 58: 9991003